<DOC>
	<DOCNO>NCT01474291</DOCNO>
	<brief_summary>This prospective , multi-center , observational study evaluate factor influence use tocilizumab ( RoActemra/Actemra ) monotherapy rheumatoid arthritis patient real life set . Data collect participant 12 month follow initiation tocilizumab treatment .</brief_summary>
	<brief_title>An Observational Study RoActemra/Actemra ( Tocilizumab ) As Monotherapy Rheumatoid Arthritis Patients Routine Clinical Practice</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Adult participant , &gt; /= 18 year age Patients rheumatoid arthritis rheumatologist decides start tocilizumab combination DMARD monotherapy Current participation clinical trial rheumatoid arthritis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>